FIGURE

Figure 3

ID

ZDB-FIG-221226-188

Publication

Silva et al., 2022 - Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

Migration and invasion of CRC cell lines HCT116, HT-29, and SW480 upon treatment with deflamin: (A) Analysis of migration by the wound healing assay of human CRC cell lines HCT116, HT-29 and SW480 treated with deflamin for 48 h and its corresponding quantification (%) (n = 3). (B) 3D spheroid invasion assay of human CRC cell lines HCT116, HT-29, and SW480 treated with deflamin and the corresponding quantification (number of absolute invasive cells). The number of spheroids analyzed is indicated in the graphs. Statistical analysis was performed as described in the Statistical Analysis section (*, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers